Cells therapy for Parkinson's disease-so close and so far away

Science in China, Series C: Life Sciences

Volumn 52, Issue 7, 2009, Pages 610-614

  Ren, ZhenHua ^a   Zhang, Yu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Carotid body; Cell replacement; Dopamine neurons; Embryonic stem cells; Fetal ventral mesencephalon; Induced pluripotent stem cells; Nuclear transfer embryonic stem cells; Parkinson's disease; Stem cell; Transplantation

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

BIOLOGICAL THERAPY; CAROTID BODY; CELL TRANSPLANTATION; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; HUMAN; MESENCEPHALON; METHODOLOGY; PARKINSON DISEASE; PHYSIOLOGY; REVIEW; STEM CELL TRANSPLANTATION;

CAROTID BODY; CELL TRANSPLANTATION; CORD BLOOD STEM CELL TRANSPLANTATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MESENCEPHALON; PARKINSON DISEASE; STEM CELL TRANSPLANTATION; TISSUE THERAPY;

ANIMALIA; IPS; RODENTIA;

EID: 70350041134     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-009-0090-8     Document Type: Review

References (32)

1. Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science, 1990, 247: 574-577.
2. Freed C R, Greene P E, Breeze R E, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med, 2001, 344: 710-719.
3. Olanow C W, Goetz C G, Kordower J H, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol, 2003, 54: 403-414.
4. Li J Y, Englund E, Holton J L, et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med, 2008, 14: 501-503.
5. Kordower J H, Chu Y, Hauser R A, et al. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med, 2008, 14: 504-506.
6. Mendez I, Vinuela A, Astradsson A, et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med, 2008, 14: 507-509.
7. Newman M B, Bakay R A. Therapeutic potentials of human embryonic stem cells in Parkinson's disease. Neurotherapeutics, 2008, 5: 237-251.
8. Bjugstad K B, Teng Y D, Redmond D E Jr, et al. Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease. Exp Neurol, 2008, 211: 362-369.
9. Tabar V, Tomishima M, Panagiotakos G, et al. Therapeutic cloning in individual parkinsonian mice. Nat Med, 2008, 14: 379-381.
10. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell, 2007, 1: 39-49.
11. Pardal R, Ortega-Sáenz P, Durán R, et al. Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body. Cell, 2007, 131: 364-377.
12. Park H J, Lee P H, Bang O Y, et al. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease. J Neurochem, 2008, 107: 141-151.
13. Friling S, Andersson E, Thompson L H, et al. Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci USA, 2009, 106: 7613-7618.
14. Shimada H, Yoshimura N, Tsuji A, et al. Differentiation of dopaminergic neurons from human embryonic stem cells: Modulation of differentiation by FGF-20. J Biosci Bioeng, 2009, 107: 447-454.
15. Lee S H, Lumelsky N, Studer L, et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol, 2000, 18: 675-679.
16. Bjorklund L M, Sánchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA, 2002, 99: 2344-2349.
17. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126: 663-676.
18. Wernig M, Zhao J P, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA, 2008, 105: 5856-5861.
19. Svendsen C. Stem cells and Parkinson's disease: Toward a treatment, not a cure. Cell Stem Cell, 2008, 2: 412-413.
20. McKay R, Kittappa R. Will stem cell biology generate new therapies for Parkinson's disease? Neuron, 2008, 58: 659-661.
21. Espejo E F, Montoro R J, Armengol J A, et al. Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates. Neuron, 1998, 20: 197-206.
22. Toledo-Aral J J, Méndez-Ferrer S, Pardal R, et al. Dopaminergic cells of the carotid body: Physiological significance and possible therapeutic applications in Parkinson's disease. Brain Res Bull, 2002, 57: 847-853.
23. Kokovay E, Temple S. Taking neural crest stem cells to new heights. Cell, 2007, 131: 234-236.
24. Hong M, Mukhida K, Mendez I. GDNF therapy for Parkinson's disease. Expert Rev Neurother, 2008, 8: 1125-1139.
25. Gill S S, Patel N K, Hotton G R, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med, 2003, 9: 589-595.
26. Patel N K, Bunnage M, Plaha P, et al. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: A two-year outcome study. Ann Neurol (2005). 57: 298-302.
27. Slevin J T, Gerhardt G A, Smith C D, et al. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J Neurosurg, 2005, 102: 216-222.
28. Peck P. Amgen decision to halt GDNF clinical trials and withdraw the drug triggers protest from researchers and patients. Neurol Today, Am Acad Neurol, 2005, 5: 4, 7, 24.
29. Nutt J G, Burchiel K J, Comella C L, et al. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology, 2003, 60: 69-73.
30. Morrison P F, Lonser R R, Oldfield E H. Convective delivery of glial cell line-derived neurotrophic factor in the human putamen. J Neurosurg, 2007, 107: 74-83.
31. Elsworth J D, Redmond D E Jr, Leranth C, et al. AAV2-mediated gene transfer of GDNF to the striatum of MPTP monkeys enhances the survival and outgrowth of co-implanted fetal dopamine neurons. Exp Neurol, 2008, 211: 252-258.
32. Emborg M E, Ebert A D, Moirano J, et al. GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys. Cell Transplant, 2008, 17: 383-395.